Upstage Lung Cancer

Using performing arts to raise awareness and funding for lung cancer research

Donate Today

2018-2019 we support CRISPR- based lung cancer detection research by Edwin Yau, MD, PhD.

Upstage Lung Cancer is very grateful for your charitable contribution. With your support, we have been able to invest over $2 million in cutting-edge research to help find new life-saving methods for the early detection of lung cancer. We appreciate every dollar you contribute. We will continue to work tirelessly with our partners to bring hope to those battling the disease.

 

or

 

Making a donation in honor or memory of someone? Use the donation button above and when you get to the second screen titled “info”, please click on the purple text at the bottom that reads “make this donation in …”.

Donate with confidence. GuideStar USA, Inc. is a nonprofit information service specializing in reporting on U.S. nonprofit companies. Their objective is to revolutionize philanthropy by providing information that advances transparency, enables users to make better investments, and encourages charitable giving. GuideStar’s gold star rating was granted to Upstage Lung Cancer for providing the highest level of disclosure about mission, legitimacy, impact, reputation, finances, programs, transparency, governance, and so much more. GuideStar remains neutral while collecting, organizing, and presenting the information a donor needs to make the best decisions possible.

“If there be any truer measure of a man than by what he does, it must be by what he gives.”
— Robert South (1634-1716)

Please give as generously as you can.

We can accommodate donations made in Honor or Memory of someone (see above for instructions), or employer matching programs.

Thank you.

Upstage Lung Cancer is a 501(c)(3) nonprofit organization. All donations are tax deductible to the full extent of the law. All information you share with Upstage Lung Cancer is strictly confidential. We will not give, sell or otherwise distribute any information received.